Markets:

Overview

News

Currencies

International

Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.380 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

32 33 34 35 36 37 38 39 Next >

Mid-Morning Market Update: Markets Open Higher; Big Lots Reports Downbeat Profit ↗

August 27, 2021

Following the market opening Friday, the Dow traded up 0.30% to 35,320.11 while the NASDAQ rose 0.27% to 14,986.36. The S&P also rose, gaining 0.33% to 4,484.57. The U.S. has...

Via Benzinga

Topics Stocks

63 Biggest Movers From Yesterday ↗

August 27, 2021

Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...

Via Benzinga

CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences on Behalf of Cassava Sciences Stockholders and Encourages Investors to Contact the Firm

August 26, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

CASSAVA SHAREHOLDER ALERT

August 26, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm

August 26, 2021

From The Schall Law Firm

Via Business Wire

Why Traders Shouldn’t Bargain Hunt in Cassava Stock ↗

August 26, 2021

Wall Street is notorious for its overreactions, but when it comes to SAVA stock's cratering, investors consider other historical precedents.

Via InvestorPlace

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – SAVA

August 26, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

As Allegations Swirl, Can Investors Still Count on Cassava Sciences Stock? ↗

August 26, 2021

This once-promising biotech is now struggling to stay afloat.

Via The Motley Fool

Better Biotech Stock: Cassava Sciences vs. Annovis Bio ↗

August 26, 2021

It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment.

Via The Motley Fool

GameStop Continues To See Sky-High WallStreetBets Interest; AMC, BlackBerry, Alibaba, Palantir Are Other Top Trends ↗

August 25, 2021

GameStop Corp. (NYSE:GME) continued to be the most-discussed ...

Via Benzinga

54 Biggest Movers From Yesterday ↗

August 26, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc. and Encourages Investors with Losses to Contact the Firm

August 25, 2021

From The Schall Law Firm

Via Business Wire

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

CASSAVA INVESTOR ALERT

August 25, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Law Offices of Howard G. Smith

Via Business Wire

SAVA Stock: Cassava Sciences Sinks Despite Countering Trial Data Allegations ↗

August 25, 2021

Today, investors in Cassava Sciences and SAVA stock are seeing a lot of red, as investors digest a statement of concern filed yesterday.

Via InvestorPlace

Mid-Afternoon Market Update: Dow Rises 100 Points; ScanSource Shares Surge Following Q4 Results ↗

August 25, 2021

Toward the end of trading Wednesday, the Dow traded up 0.30% to 35,470.78 while the NASDAQ rose 0.12% to 15,038.45. The S&P also rose, gaining 0.28% to 4,498.64. The U.S. has...

Via Benzinga

Topics Stocks

S&P 500, Nasdaq Extend Records on Delta Variant Decline ↗

August 25, 2021

The S&P 500 Index and Nasdaq Composite are on the rise midday, extending yesterday's record closes and nabbing fresh intraday highs.

Via Talk Markets

Topics Stocks

2 Little-Known Nasdaq Stocks Making Big Moves Wednesday ↗

August 25, 2021

Don't let these companies fly under your radar.

Via The Motley Fool

Topics Stocks

SAVA Stock: The Allegations That Have Cassava Sciences Sinking Today ↗

August 25, 2021

Shares of SAVA stock are crashing on Wednesday after allegations about Cassava Sciences' Alzheimer's disease treatment are being reviewed.

Via InvestorPlace

The Law Offices of Frank R. Cruz Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...

Via Benzinga

Mid-Day Market Update: Gold Down 1%; Locust Walk Acquisition Shares Jump ↗

August 25, 2021

Midway through trading Wednesday, the Dow traded up 0.20% to 35,435.82 while the NASDAQ rose 0.05% to 15,027.49. The S&P also rose, gaining 0.14% to 4,492.54. The U.S. has the...

Via Benzinga

Topics Stocks

36 Stocks Moving In Wednesday's Mid-Day Session ↗

August 25, 2021

Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...

Via Benzinga

Here's Why Cassava Sciences Is Having a Bad Day ↗

August 25, 2021

The FDA received a citizen petition requesting a halt to clinical trials with the company's Alzheimer's disease candidate.

Via The Motley Fool

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors

August 25, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

Mid-Morning Market Update: Markets Edge Higher; Dick's Sporting Goods Beats Q2 Views ↗

August 25, 2021

Following the market opening Wednesday, the Dow traded up 0.07% to 35,389.32 while the NASDAQ rose 0.17% to 15,045.45. The S&P also rose, gaining 0.14% to 4,492.57. The U.S....

Via Benzinga

Topics Stocks

Cassava Sciences Stock Shows Promise With Simufilam Trials Drawing Near ↗

August 25, 2021

SAVA stock is up as the company announced the FDA has agreed on study protocols for Phase 3 clinical trials of Simufilam.

Via InvestorPlace

Cassava Stock Plummets On Claims Of 'Data Manipulation' In Alzheimer's Testing ↗

August 25, 2021

A shareholder firm called for the FDA to halt Cassava Sciences' studies in Alzheimer's disease, leading SAVA stock to plummet Wednesday.

Via Investor's Business Daily

< Previous 1 2

...

32 33 34 35 36 37 38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.